Showing 341 - 360 of 1740 results
This week marks 20 years since ANSTO’s OPAL multi-purpose reactor first achieved criticality - a defining moment for Australian nuclear science and the beginning of two decades of discoveries, medical advances and industrial innovation delivered from ANSTO’s Lucas Heights campus.
A large international collaboration has developed a straightforward and cost-effective synthesizing approach using a 3D printing technique to produce single atom catalysts (SACs)—potentially paving the way for large scale commercial production with broad industrial applications.
The Australian Government recently signed a landmark emissions reduction technology deal with Great Britain, which includes nuclear energy and clean hydrogen among the six key low emission technologies the two countries hope to advance.
A team of scientists led by Monash University and the University of Melbourne in association with the Peter Doherty Institute for Infection and Immunity have made progress in clarifying the molecular interactions that underpin how our adaptive immune cells recognise SARS CoV-2, which causes COVID-19.
The National Deuteration Facility is providing deuterated cholesterol, an essential ingredient in lipid nanoparticles for the delivery of vaccines using mRNA, to academic and industry partners.
During the scheduled shutdown of the OPAL multi-purpose reactor, an ANSTO engineering and project team has installed a new safety shutdown instrumentation and control system (I&C).
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program
ANSTO scientists will contribute to a new $1 million ARC Linkage Project grant to evaluate human responses to post glacial sea level rise at Red Lily, Arnhem land led by Griffith University.
PNG researcher provides a progress update on an aquaculture project to improve the industry and benefit the local population